StockData
Akso Health Group logo

Akso Health Group (AHG) stock

AHGNasdaqServices-Business Services, NECFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 23, 2026Score 7/30
$1.24−0.09 (-6.77%)

Close on Nov 17, 2026Market cap $1.06BP/E 41.3Yield –

Akso Health r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2022 it was $421.19K, down 4.6% from the year before. The highest annual figure on record is $2.82M in fiscal 2018.

Annual r&d expenses

PeriodPeriod endValueChange
FY2022Mar 31, 2022$421.19K-4.6%
FY2021Mar 31, 2021$441.41K+274.3%
FY2020Mar 31, 2020$117.94K–
FY2019Mar 31, 2019$0-100.0%
FY2018Mar 31, 2018$2.82M+79.7%
FY2017Mar 31, 2017$1.57M+75.0%
FY2016Mar 31, 2016$895.99K–

More Akso Health figures

See a number that looks wrong?